Article(id=1329914607851909190, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1329914534925545632, articleNumber=null, orderNo=null, doi=10.16522/j.cnki.cjph.2024.08.015, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1715011200000, receivedDateStr=2024-05-07, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1795005951129, onlineDateStr=2026-11-18, pubDate=1723219200000, pubDateStr=2024-08-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1795005951129, onlineIssueDateStr=2026-11-18, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1795005951129, creator=13701087609, updateTime=1795005951129, updator=13701087609, issue=Issue{id=1329914534925545632, tenantId=1146029695717560320, journalId=1319690259887390882, year='2024', volume='55', issue='8', pageStart='1045', pageEnd='1169', issueExtLink='null', onlineDate='null', pubDate='1723219200000', pubDateStr='2024-08-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1795005933743, creator='13701087609', updateTime=1795136196326, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1330460896280818483, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1329914534925545632, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1330460896280818484, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1329914534925545632, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=1136, endPage=1142, ext={EN=ArticleExt(id=1329914608099373128, articleId=1329914607851909190, tenantId=1146029695717560320, journalId=1319690259887390882, language=EN, title=Considerations for the Plasmid Designing and Compliance of Recombinant Adeno-associated Virus Vector Production, columnId=1329914608015487047, journalTitle=Chinese Journal of Pharmaceuticals, columnName=Development and Production Quality Control of Gene Drugs, runingTitle=null, highlight=null, articleAbstract=

At present, recombinant adeno-associated virus is the most commonly used vectors for in vivo gene therapy products. For producing virus vectors, plasmids are believed to be the important starting raw material. The designing and managing of plasmids directly contribute to the biological mechanisms, pharmaceutical properties, efficacy, and safety of products. Therefore, understanding the properties of plasmids and their gene elements is the basis for the “quality by design” of such products. The functions of different plasmids are introduced in this paper, the construction of main genetic elements are summarized, the considerations for designing of plasmids are discussed, the compliance for developing and manufacturing of plasmids are reviewed, in order to provide some references for the development and management of gene therapy products, especially for the recombinant adeno-associated virus products.

, authors=Yifei CHEN1, Linsha MA2, Fen LIU1, *, authorsList=Yifei CHEN, Linsha MA, Fen LIU, authorCompany=null, correspAuthors=Fen LIU, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1329914608665604171, articleId=1329914607851909190, tenantId=1146029695717560320, journalId=1319690259887390882, language=CN, title=重组腺相关病毒载体生产用质粒的设计与合规考量, columnId=1329914608187453513, journalTitle=中国医药工业杂志, columnName=基因药物的开发与生产质量控制专栏, runingTitle=null, highlight=null, articleAbstract=

重组腺相关病毒是当前体内基因治疗产品中最常用的载体。在其生产中,质粒是重要的起始原材料。质粒的设计与管理直接决定了产品的生物学作用机制、药学性质、有效性与安全性。因此,对质粒及其基因元件性质的理解是该类产品“质量源于设计”的管理基础。文章以商业化生产中常用的三质粒系统为例,概述了不同质粒的作用,介绍了主要基因元件,分析了质粒的设计要点,综述了合规要求,讨论了质粒的设计与合规考量,以期为以重组腺相关病毒为代表的基因治疗产品的开发和管理提供参考。

, authors=陈一飞1, 马琳莎2, 刘芬1, *, authorsList=陈一飞, 马琳莎, 刘芬, authorCompany=null, correspAuthors=刘芬, authorNote=

陈一飞(1983—),女,副研究员,从事药物非临床安全性评价与药品监管科学研究。

, correspAuthorsNote=
刘芬(1986—),女,高级工程师,从事药品监管科学研究。E-mail:
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=P6H7+GHp5SFYIORaKmMCtQ==, magXml=g70RYVNQ8Q5GQRgel9Cq2Q==, pdfUrl=null, pdf=R4t2kDcm74QAOY3fCO1jQA==, pdfFileSize=2200861, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=8HO3TnONpdxCNJuLPiXKNw==, mapNumber=null, fund=null)}, authors=[Author(id=1329914609139560531, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329914609240223829, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, authorId=1329914609139560531, language=EN, stringName=Yifei CHEN, firstName=Yifei, middleName=null, lastName=CHEN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.Shanghai Center for Drug Evaluation and Inspection, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329914609303138390, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, authorId=1329914609139560531, language=CN, stringName=陈一飞, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.上海药品审评核查中心,上海 201203, bio={"content":"

陈一飞(1983—),女,副研究员,从事药物非临床安全性评价与药品监管科学研究。

"}, bioImg=null, bioContent=

陈一飞(1983—),女,副研究员,从事药物非临床安全性评价与药品监管科学研究。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329914608892096588, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, xref=1., ext=[AuthorCompanyExt(id=1329914608900485197, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, companyId=1329914608892096588, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Shanghai Center for Drug Evaluation and Inspection, Shanghai 201203), AuthorCompanyExt(id=1329914608946622542, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, companyId=1329914608892096588, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.上海药品审评核查中心,上海 201203)])]), Author(id=1329914609382830168, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329914609466716250, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, authorId=1329914609382830168, language=EN, stringName=Linsha MA, firstName=Linsha, middleName=null, lastName=MA, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.South China Agricultural University, Guangzhou 510642, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329914609538019419, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, authorId=1329914609382830168, language=CN, stringName=马琳莎, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.华南农业大学,广东 广州 510642, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329914609034702927, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, xref=2., ext=[AuthorCompanyExt(id=1329914609038897232, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, companyId=1329914609034702927, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.South China Agricultural University, Guangzhou 510642), AuthorCompanyExt(id=1329914609047285841, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, companyId=1329914609034702927, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.华南农业大学,广东 广州 510642)])]), Author(id=1329914609600933981, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=ysliufen@smda.sh.cn, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329914609668042847, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, authorId=1329914609600933981, language=EN, stringName=Fen LIU, firstName=Fen, middleName=null, lastName=LIU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.Shanghai Center for Drug Evaluation and Inspection, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329914609735151712, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, authorId=1329914609600933981, language=CN, stringName=刘芬, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.上海药品审评核查中心,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329914608892096588, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, xref=1., ext=[AuthorCompanyExt(id=1329914608900485197, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, companyId=1329914608892096588, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Shanghai Center for Drug Evaluation and Inspection, Shanghai 201203), AuthorCompanyExt(id=1329914608946622542, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, companyId=1329914608892096588, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.上海药品审评核查中心,上海 201203)])])], keywords=[Keyword(id=1329914609840009313, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, language=EN, orderNo=1, keyword=gene therapy product), Keyword(id=1329914609902923874, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, language=EN, orderNo=2, keyword=recombinant adeno-associated virus vector), Keyword(id=1329914609965838435, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, language=EN, orderNo=3, keyword=plasmid), Keyword(id=1329914610041335908, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, language=EN, orderNo=4, keyword=design), Keyword(id=1329914610112639077, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, language=EN, orderNo=5, keyword=compliance), Keyword(id=1329914610183942246, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, language=CN, orderNo=1, keyword=基因治疗产品), Keyword(id=1329914610297188455, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, language=CN, orderNo=2, keyword=重组腺相关病毒载体), Keyword(id=1329914610360103016, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, language=CN, orderNo=3, keyword=质粒), Keyword(id=1329914610427211881, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, language=CN, orderNo=4, keyword=设计), Keyword(id=1329914610506903658, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, language=CN, orderNo=5, keyword=合规)], refs=[Reference(id=1329914610712424555, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=MEZZINA M, MERTEN O W.Adeno-associated viruses [J].Methods Mol Biol, 2011, 737: 211-234., articleTitle=null, refAbstract=null), Reference(id=1329914610792116332, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=CHUNG T W.Scale up of Sf9/BEVS-based AAV production process for GMP-manufacturing of cardiovascular gene therapies [EB/OL].(2023-04-23)[2023-09-19].https://dc.engconfintl.org/ccexviii/34/., articleTitle=null, refAbstract=null), Reference(id=1329914610863419501, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=NASO M F, TOMKOWICZ B, PERRY W L 3rd, et al.Adeno-associated virus (AAV) as a vector for gene therapy [J].BioDrugs, 2017, 31(4): 317-334., articleTitle=null, refAbstract=null), Reference(id=1329914610980860014, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=YOUNG P.Treatment to cure: advancing AAV gene therapy manufacture [J].Drug Discov Today, 2023, 28(7): 103610., articleTitle=null, refAbstract=null), Reference(id=1329914611056357487, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=SCHULTZ B R, CHAMBERLAIN J S.Recombinant adeno-associated virus transduction and integration [J].Mol Ther, 2008, 16(7): 1189-1199., articleTitle=null, refAbstract=null), Reference(id=1329914611140243568, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=ROBERT M A, CHAHAL P S, AUDY A, et al.Manufacturing of recombinant adeno-associated viruses using mammalian expression platforms [J].Biotechnol J, 2017, 12(3): 1600193., articleTitle=null, refAbstract=null), Reference(id=1329914611232518257, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=SAMULSKI R J, MUZYCZKA N.AAV-mediated gene therapy for research and therapeutic purposes [J].Annu Rev Virol, 2014, 1(1): 427-451., articleTitle=null, refAbstract=null), Reference(id=1329914611299627122, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=GRIEGER J C, CHOI V W, SAMULSKI R J.Production and characterization of adeno-associated viral vectors [J].Nat Protoc, 2006, 1(3): 1412-1428., articleTitle=null, refAbstract=null), Reference(id=1329914611379318899, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=ISSA S S, SHAIMARDANOVA A A, SOLOVYEVA V V, et al.Various AAV serotypes and their applications in gene therapy: an overview [J].Cells, 2023, 12(5): 785., articleTitle=null, refAbstract=null), Reference(id=1329914611467399284, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=MEIER A F, FRAEFEL C, SEYFFERT M.The interplay between adeno-associated virus and its helper viruses [J].Viruses, 2020, 12(6): 662., articleTitle=null, refAbstract=null), Reference(id=1329914611555479669, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=派真生物.国际罕见病日丨派真生物GMP质粒获DMF备案,助力药物申报,为罕见生命点亮色彩! [EB/OL].(2023-03-02)[2023-10-11].https://www.packgene.cn/news-cn/dmf/., articleTitle=null, refAbstract=null), Reference(id=1329914611614199926, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA.List of drug master files (DMFs)[EB/OL].(2023-10-10)[2023-10-11].https://www.fda.gov/drugs/drug-master-files-dmfs/list-drug-master-files-dmfs., articleTitle=null, refAbstract=null), Reference(id=1329914611756806263, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=POWELL S K, RIVERA-SOTO R, GRAY S J.Viral expression cassette elements to enhance transgene target specificity and expression in gene therapy [J].Discov Med, 2015, 19(102): 49-57., articleTitle=null, refAbstract=null), Reference(id=1329914611832303736, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=BELL P, MOSCIONI A D, MCCARTER R J, et al.Analysis of tumors arising in male B6C3F1 mice with and without AAV vector delivery to liver [J].Mol Ther, 2006, 14(1): 34-44., articleTitle=null, refAbstract=null), Reference(id=1329914611886829689, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=DONSANTE A, VOGLER C, MUZYCZKA N, et al.Observed incidence of tumorigenesis in long-term rodent studies of rAAV vectors [J].Gene Ther, 2001, 8(17): 1343-1346., articleTitle=null, refAbstract=null), Reference(id=1329914611979104378, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=ROSAS L E, GRIEVES J L, ZARASPE K, et al.Patterns of scAAV vector insertion associated with oncogenic events in a mouse model for genotoxicity [J].Mol Ther, 2012, 20(11): 2098-2110., articleTitle=null, refAbstract=null), Reference(id=1329914612067184763, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=CHANDLER R J, LAFAVE M C, VARSHNEY G K, et al.Vector design influences hepatic genotoxicity after adeno-associated virus gene therapy [J].J Clin Invest, 2015, 125(2): 870-880., articleTitle=null, refAbstract=null), Reference(id=1329914612134293628, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=GRAY S J, FOTI S B, SCHWARTZ J W, et al.Optimizing promoters for recombinant adeno-associated virus-mediated gene expression in the peripheral and central nervous system using self-complementary vectors [J].Hum Gene Ther, 2011, 22(9): 1143-1153., articleTitle=null, refAbstract=null), Reference(id=1329914612209791101, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=TENENBAUM L, CHTARTO A, LEHTONEN E, et al.Recombinant AAV-mediated gene delivery to the central nervous system [J].J Gene Med, 2004, 6(Suppl 1): S212-S222., articleTitle=null, refAbstract=null), Reference(id=1329914612272705662, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=GEISLER A, FECHNER H.MicroRNA-regulated viral vectors for gene therapy [J].World J Exp Med, 2016, 6(2): 37-54., articleTitle=null, refAbstract=null), Reference(id=1329914612356591743, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=WANG J H, GESSLER D J, ZHAN W, et al.Adeno-associated virus as a delivery vector for gene therapy of human diseases[J].Signal Transduct Target Ther, 2024, 9(1): 78., articleTitle=null, refAbstract=null), Reference(id=1329914612415312000, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=PAN X F, YUE Y P, BOFTSI M, et al.Rational engineering of a functional CpG-free ITR for AAV gene therapy [J].Gene Ther, 2022, 29(6): 333-345., articleTitle=null, refAbstract=null), Reference(id=1329914612490809473, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=BALAKRISHNAN B, JAYANDHARAN G R.Basic biology of adeno-associated virus(AAV) vectors used in gene therapy[J].Curr Gene Ther, 2014, 14(2): 86-100., articleTitle=null, refAbstract=null), Reference(id=1329914612557918338, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=GEORGE L A, RAGNI M V, RASKO J E J, et al.Long-term follow-up of the first in human intravascular delivery of AAV for gene transfer: AAV2-hFIX16 for severe hemophilia B [J].Mol Ther, 2020, 28(9): 2073-2082., articleTitle=null, refAbstract=null), Reference(id=1329914612650193027, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=SRIVASTAVA A, CARTER B J.AAV infection: protection from cancer [J].Hum Gene Ther, 2017, 28(4): 323-327., articleTitle=null, refAbstract=null), Reference(id=1329914612708913284, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=NATHWANI A C, REISS U, TUDDENHAM E, et al.Adeno-associated mediated gene transfer for hemophilia B: 8 year follow up and impact of removing “empty viral particles” on safety and efficacy of gene transfer [J].Blood, 2018, 132(S1): 491., articleTitle=null, refAbstract=null), Reference(id=1329914612780216453, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=NGUYEN G N, EVERETT J K, KAFLE S, et al.A long-term study of AAV gene therapy in dogs with hemophilia A identifies clonal expansions of transduced liver cells [J].Nat Biotechnol, 2021, 39(1): 47-55., articleTitle=null, refAbstract=null), Reference(id=1329914612847325318, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=NAKAI H, IWAKI Y, KAY M A, et al.Isolation of recombinant adeno-associated virus vector-cellular DNA junctions from mouse liver [J].J Virol, 1999, 73(7): 5438-5447., articleTitle=null, refAbstract=null), Reference(id=1329914612927017095, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[29], rfOrder=28, authorNames=null, journalName=null, refType=null, unstructuredReference=RUTLEDGE E A, RUSSELL D W.Adeno-associated virus vector integration junctions [J].J Virol, 1997, 71(11): 8429-8436., articleTitle=null, refAbstract=null), Reference(id=1329914612998320264, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[30], rfOrder=29, authorNames=null, journalName=null, refType=null, unstructuredReference=YANG C C, XIAO X, ZHU X, et al.Cellular recombination pathways and viral terminal repeat hairpin structures are sufficient for adeno-associated virus integration in vivo and in vitro [J].J Virol, 1997, 71(12): 9231-9247., articleTitle=null, refAbstract=null), Reference(id=1329914613073817737, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[31], rfOrder=30, authorNames=null, journalName=null, refType=null, unstructuredReference=CHANDLER R J, SANDS M S, VENDITTI C P.Recombinant adeno-associated viral integration and genotoxicity: insights from animal models [J].Hum Gene Ther, 2017, 28(4): 314-322., articleTitle=null, refAbstract=null), Reference(id=1329914613153509514, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[32], rfOrder=31, authorNames=null, journalName=null, refType=null, unstructuredReference=DALWADI D A, TORRENS L, ABRIL-FORNAGUERA J,et al.Liver injury increases the incidence of HCC following AAV gene therapy in mice [J].Mol Ther, 2021, 29(2): 680-690., articleTitle=null, refAbstract=null), Reference(id=1329914613220618379, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[33], rfOrder=32, authorNames=null, journalName=null, refType=null, unstructuredReference=GIL-FARINA I, FRONZA R, KAEPPEL C, et al.Recombinant AAV integration is not associated with hepatic genotoxicity in nonhuman primates and patients [J].Mol Ther, 2016, 24(6): 1100-1105., articleTitle=null, refAbstract=null), Reference(id=1329914613321281676, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[34], rfOrder=33, authorNames=null, journalName=null, refType=null, unstructuredReference=MILLER D G, TROBRIDGE G D, PETEK L M, et al.Large-scale analysis of adeno-associated virus vector integration sites in normal human cells [J].J Virol, 2005, 79(17): 11434-11442., articleTitle=null, refAbstract=null), Reference(id=1329914613413556365, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[35], rfOrder=34, authorNames=null, journalName=null, refType=null, unstructuredReference=SULLIVAN L, ZAHN M, FARINA I G, et al.Rare genomic integrations of AAV5-hFⅧ-SQ occur without evidence of clonal activation or gene-specific targeting [J].Mol Ther, 2021, 29(4): 425., articleTitle=null, refAbstract=null), Reference(id=1329914613539385486, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[36], rfOrder=35, authorNames=null, journalName=null, refType=null, unstructuredReference=WANG P R, XU M, TOFFANIN S, et al.Induction of hepatocellular carcinoma by in vivo gene targeting [J].Proc Natl Acad Sci U S A, 2012, 109(28): 11264-11269., articleTitle=null, refAbstract=null), Reference(id=1329914613631660175, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[37], rfOrder=36, authorNames=null, journalName=null, refType=null, unstructuredReference=LOU J, YAN W, LI Q Y, et al.LncRNA MEG8 plays an oncogenic role in hepatocellular carcinoma progression through miR-367-3p/14-3-3ζ/TGFβR1 axis [J].Neoplasma, 2021, 68(2): 273-282., articleTitle=null, refAbstract=null), Reference(id=1329914613761683600, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[38], rfOrder=37, authorNames=null, journalName=null, refType=null, unstructuredReference=国家药品监督管理局药品审评中心.重组腺相关病毒载体类体内基因治疗产品临床试验申请药学研究与评价技术指导原则[EB/OL].(2024-01-19)[2024-06-04].https://www.cde.org.cn/zdyz/domesticinfopage?zdyzId-CODE=50e5084c5744f082a85dd7e4eb068703., articleTitle=null, refAbstract=null), Reference(id=1329914613849763985, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[39], rfOrder=38, authorNames=null, journalName=null, refType=null, unstructuredReference=SABATINO D E, BUSHMAN F D, CHANDLER R J, et al.Evaluating the state of the science for adeno-associated virus integration: an integrated perspective [J].Mol Ther, 2022, 30(8): 2646-2663., articleTitle=null, refAbstract=null), Reference(id=1329914613921067154, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[40], rfOrder=39, authorNames=null, journalName=null, refType=null, unstructuredReference=MILLER D G, PETEK L M, RUSSELL D W.Adeno-associated virus vectors integrate at chromosome breakage sites [J].Nat Genet, 2004, 36(7): 767-773., articleTitle=null, refAbstract=null), Reference(id=1329914614030119059, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[41], rfOrder=40, authorNames=null, journalName=null, refType=null, unstructuredReference=WEBER T.Anti-AAV antibodies in AAV gene therapy: current challenges and possible solutions [J].Front Immunol, 2021, 12: 658399., articleTitle=null, refAbstract=null), Reference(id=1329914614105616532, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[42], rfOrder=41, authorNames=null, journalName=null, refType=null, unstructuredReference=WANG D, TAI P W L, GAO G P.Adeno-associated virus vector as a platform for gene therapy delivery [J].Nat Rev Drug Discov, 2019, 18(5): 358-378., articleTitle=null, refAbstract=null), Reference(id=1329914614164336789, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[43], rfOrder=42, authorNames=null, journalName=null, refType=null, unstructuredReference=IKEDA T, YAMAGUCHI Y, OYAMA H, et al.Higher-order structure of adeno-associated virus serotype 8 by hydrogen/deuterium exchange mass spectrometry [J].Viruses, 2024, 16(4): 585., articleTitle=null, refAbstract=null), Reference(id=1329914614231445654, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[44], rfOrder=43, authorNames=null, journalName=null, refType=null, unstructuredReference=MENDELL J R, AL-ZAIDY S, SHELL R, et al.Single-dose gene-replacement therapy for spinal muscular atrophy [J].N Engl J Med, 2017, 377(18): 1713-1722., articleTitle=null, refAbstract=null), Reference(id=1329914614311137431, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[45], rfOrder=44, authorNames=null, journalName=null, refType=null, unstructuredReference=MENG J S, HE Y, YANG H B, et al.Melittin analog p5RHH enhances recombinant adeno-associated virus transduction efficiency [J].J Integr Med, 2024, 22(1): 72-82., articleTitle=null, refAbstract=null), Reference(id=1329914614420189336, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[46], rfOrder=45, authorNames=null, journalName=null, refType=null, unstructuredReference=EL ANDARI J, GRIMM D.Production, processing, and characterization of synthetic AAV gene therapy vectors [J].Biotechnol J, 2021, 16(1): e2000025., articleTitle=null, refAbstract=null), Reference(id=1329914614483103897, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[47], rfOrder=46, authorNames=null, journalName=null, refType=null, unstructuredReference=国家药品监督管理局药品审评中心.体内基因治疗产品药学研究与评价技术指导原则(试行)[EB/OL].(2022-05-31)[2023-10-02].https://www.cde.org.cn/zdyz/domes-ticinfopage?zdyzIdCODE=c78a179af7edac00e6d8893dcd-fef01f., articleTitle=null, refAbstract=null), Reference(id=1329914614546018458, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[48], rfOrder=47, authorNames=null, journalName=null, refType=null, unstructuredReference=基因治疗制品质量控制概述[J].中国药事,2023,37(6):611-644., articleTitle=null, refAbstract=null), Reference(id=1329914614634098843, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[49], rfOrder=48, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA.Guidance for industry: considerations for plasmid DNA vaccines for infectious disease indications [EB/OL].[2023-10-12].https://www.fda.gov/media/73667/download., articleTitle=null, refAbstract=null)], funds=null, companyList=[AuthorCompany(id=1329914608892096588, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, xref=1., ext=[AuthorCompanyExt(id=1329914608900485197, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, companyId=1329914608892096588, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Shanghai Center for Drug Evaluation and Inspection, Shanghai 201203), AuthorCompanyExt(id=1329914608946622542, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, companyId=1329914608892096588, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.上海药品审评核查中心,上海 201203)]), AuthorCompany(id=1329914609034702927, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, xref=2., ext=[AuthorCompanyExt(id=1329914609038897232, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, companyId=1329914609034702927, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.South China Agricultural University, Guangzhou 510642), AuthorCompanyExt(id=1329914609047285841, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, companyId=1329914609034702927, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.华南农业大学,广东 广州 510642)])], figs=null, attaches=null, journal=Journal(id=1319689822849302687, delFlag=0, nameCn=中国医药工业杂志, nameEn=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, issn=1001-8255, eissn=null, cn=31-1243/R, coden=ZYGZEA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=etiWDuwx2KO274LHw88KJA==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Journal of Pharmaceuticals, journalRemark=null, publicationField=null, createdTime=1792568172420, updatedTime=1792747450744, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=Z, firstLetterEn=Z, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=etiWDuwx2KO274LHw88KJA==, picEn=ip9NF4dK57AmNrCiZ6hmdw==, jcr=null, cjcr=null, exts=[JournalExt(id=1320441770761105589, language=CN, name=中国医药工业杂志, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450771, updatedTime=1792747450771, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""}), JournalExt(id=1320441770819825846, language=EN, name=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450785, updatedTime=1792747450785, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""})], databaseList=null, tenantJournalId=1319690259887390882, websiteList=[Website(id=1319720771623174732, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/CN, language=CN, createTime=1792575551181, createBy=18614031015, updateTime=1792746040843, updateBy=18614031015, name=中国医药工业杂志-中文, tplId=1146099689490845704, title=中国医药工业杂志, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428487504769041, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=articleTextType, value=kx, createTime=1792982702375, updateTime=1792982702375, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487475408910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982702368, updateTime=1792982702368, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487538323476, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=grayFlag, value=0, createTime=1792982702383, updateTime=1792982702383, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487462825997, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982702365, updateTime=1792982702365, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487571877910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=minRunFlag, value=0, createTime=1792982702391, updateTime=1792982702391, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487496380432, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic, createTime=1792982702373, updateTime=1792982702373, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487563489301, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=silenceFlag, value=0, createTime=1792982702389, updateTime=1792982702389, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487483797519, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982702370, updateTime=1792982702370, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487517351954, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeColor, value=null, createTime=1792982702378, updateTime=1792982702378, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487525740563, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982702380, updateTime=1792982702380, creator=18614031015, updator=18614031015)]), Website(id=1319720771702866512, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/EN, language=EN, createTime=1792575551200, createBy=18614031015, updateTime=1792746037543, updateBy=18614031015, name=中国医药工业杂志-英文, tplId=1146101810881728533, title=Chinese Journal of Pharmaceuticals, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428509638111261, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=articleTextType, value=kx, createTime=1792982707652, updateTime=1792982707652, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509579391002, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982707638, updateTime=1792982707638, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509680054304, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=grayFlag, value=0, createTime=1792982707662, updateTime=1792982707662, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509566808089, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982707635, updateTime=1792982707635, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509701025826, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=minRunFlag, value=0, createTime=1792982707667, updateTime=1792982707667, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509629722652, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic, createTime=1792982707650, updateTime=1792982707650, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509688442913, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=silenceFlag, value=0, createTime=1792982707664, updateTime=1792982707664, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509587779611, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982707640, updateTime=1792982707640, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509663277086, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeColor, value=null, createTime=1792982707658, updateTime=1792982707658, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509671665695, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982707660, updateTime=1792982707660, creator=18614031015, updator=18614031015)])], journalTitle=中国医药工业杂志, weixinUrl=null, journalUrl=http://www.cjph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Journal of Pharmaceuticals, journalPhotoCn=etiWDuwx2KO274LHw88KJA==, journalPhotoEn=ip9NF4dK57AmNrCiZ6hmdw==, journalFirstLetter=Z, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2024.08.015, detailUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/10.16522/j.cnki.cjph.2024.08.015, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/PDF/10.16522/j.cnki.cjph.2024.08.015, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/PDF/10.16522/j.cnki.cjph.2024.08.015, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1723219200000, fullTextJson=null, articleText=null, reference=null)
收藏切换
重组腺相关病毒载体生产用质粒的设计与合规考量
陈一飞 1 , 马琳莎 2 , 刘芬 1, *
中国医药工业杂志 | 基因药物的开发与生产质量控制专栏 2024,55(8): 1136-1142
收起
收藏切换
中国医药工业杂志 |基因药物的开发与生产质量控制专栏 2024 , 55 (8) : 1136 -1142
重组腺相关病毒载体生产用质粒的设计与合规考量
全屏
[Author(id=1329914609139560531, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329914609240223829, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, authorId=1329914609139560531, language=EN, stringName=Yifei CHEN, firstName=Yifei, middleName=null, lastName=CHEN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.Shanghai Center for Drug Evaluation and Inspection, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329914609303138390, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, authorId=1329914609139560531, language=CN, stringName=陈一飞, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.上海药品审评核查中心,上海 201203, bio={"content":"

陈一飞(1983—),女,副研究员,从事药物非临床安全性评价与药品监管科学研究。

"}, bioImg=null, bioContent=

陈一飞(1983—),女,副研究员,从事药物非临床安全性评价与药品监管科学研究。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329914608892096588, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, xref=1., ext=[AuthorCompanyExt(id=1329914608900485197, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, companyId=1329914608892096588, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Shanghai Center for Drug Evaluation and Inspection, Shanghai 201203), AuthorCompanyExt(id=1329914608946622542, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, companyId=1329914608892096588, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.上海药品审评核查中心,上海 201203)])]), Author(id=1329914609382830168, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329914609466716250, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, authorId=1329914609382830168, language=EN, stringName=Linsha MA, firstName=Linsha, middleName=null, lastName=MA, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.South China Agricultural University, Guangzhou 510642, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329914609538019419, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, authorId=1329914609382830168, language=CN, stringName=马琳莎, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.华南农业大学,广东 广州 510642, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329914609034702927, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, xref=2., ext=[AuthorCompanyExt(id=1329914609038897232, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, companyId=1329914609034702927, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.South China Agricultural University, Guangzhou 510642), AuthorCompanyExt(id=1329914609047285841, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, companyId=1329914609034702927, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.华南农业大学,广东 广州 510642)])]), Author(id=1329914609600933981, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=ysliufen@smda.sh.cn, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329914609668042847, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, authorId=1329914609600933981, language=EN, stringName=Fen LIU, firstName=Fen, middleName=null, lastName=LIU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.Shanghai Center for Drug Evaluation and Inspection, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329914609735151712, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, authorId=1329914609600933981, language=CN, stringName=刘芬, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.上海药品审评核查中心,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329914608892096588, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, xref=1., ext=[AuthorCompanyExt(id=1329914608900485197, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, companyId=1329914608892096588, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Shanghai Center for Drug Evaluation and Inspection, Shanghai 201203), AuthorCompanyExt(id=1329914608946622542, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914607851909190, companyId=1329914608892096588, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.上海药品审评核查中心,上海 201203)])])]
陈一飞1, 马琳莎2, 刘芬1, *
作者信息
  • 1.上海药品审评核查中心,上海 201203
  • 2.华南农业大学,广东 广州 510642
通讯作者:
刘芬(1986—),女,高级工程师,从事药品监管科学研究。E-mail:
作者简介:

陈一飞(1983—),女,副研究员,从事药物非临床安全性评价与药品监管科学研究。

Considerations for the Plasmid Designing and Compliance of Recombinant Adeno-associated Virus Vector Production
Yifei CHEN1, Linsha MA2, Fen LIU1, *
Affiliations
  • 1.Shanghai Center for Drug Evaluation and Inspection, Shanghai 201203
  • 2.South China Agricultural University, Guangzhou 510642
出版时间: 2024-08-10 doi: 10.16522/j.cnki.cjph.2024.08.015
文章导航
收藏切换

重组腺相关病毒是当前体内基因治疗产品中最常用的载体。在其生产中,质粒是重要的起始原材料。质粒的设计与管理直接决定了产品的生物学作用机制、药学性质、有效性与安全性。因此,对质粒及其基因元件性质的理解是该类产品“质量源于设计”的管理基础。文章以商业化生产中常用的三质粒系统为例,概述了不同质粒的作用,介绍了主要基因元件,分析了质粒的设计要点,综述了合规要求,讨论了质粒的设计与合规考量,以期为以重组腺相关病毒为代表的基因治疗产品的开发和管理提供参考。

基因治疗产品  /  重组腺相关病毒载体  /  质粒  /  设计  /  合规

At present, recombinant adeno-associated virus is the most commonly used vectors for in vivo gene therapy products. For producing virus vectors, plasmids are believed to be the important starting raw material. The designing and managing of plasmids directly contribute to the biological mechanisms, pharmaceutical properties, efficacy, and safety of products. Therefore, understanding the properties of plasmids and their gene elements is the basis for the “quality by design” of such products. The functions of different plasmids are introduced in this paper, the construction of main genetic elements are summarized, the considerations for designing of plasmids are discussed, the compliance for developing and manufacturing of plasmids are reviewed, in order to provide some references for the development and management of gene therapy products, especially for the recombinant adeno-associated virus products.

gene therapy product  /  recombinant adeno-associated virus vector  /  plasmid  /  design  /  compliance
陈一飞, 马琳莎, 刘芬. 重组腺相关病毒载体生产用质粒的设计与合规考量. 中国医药工业杂志, 2024 , 55 (8) : 1136 -1142 . DOI: 10.16522/j.cnki.cjph.2024.08.015
Yifei CHEN, Linsha MA, Fen LIU. Considerations for the Plasmid Designing and Compliance of Recombinant Adeno-associated Virus Vector Production[J]. Chinese Journal of Pharmaceuticals, 2024 , 55 (8) : 1136 -1142 . DOI: 10.16522/j.cnki.cjph.2024.08.015

参考文献 引证文献
排序方式:
[1]
MEZZINA M, MERTEN O W.Adeno-associated viruses [J].Methods Mol Biol, 2011, 737: 211-234.
[2]
CHUNG T W.Scale up of Sf9/BEVS-based AAV production process for GMP-manufacturing of cardiovascular gene therapies [EB/OL].(2023-04-23)[2023-09-19].https://dc.engconfintl.org/ccexviii/34/.
[3]
NASO M F, TOMKOWICZ B, PERRY W L 3rd, et al.Adeno-associated virus (AAV) as a vector for gene therapy [J].BioDrugs, 2017, 31(4): 317-334.
[4]
YOUNG P.Treatment to cure: advancing AAV gene therapy manufacture [J].Drug Discov Today, 2023, 28(7): 103610.
[5]
SCHULTZ B R, CHAMBERLAIN J S.Recombinant adeno-associated virus transduction and integration [J].Mol Ther, 2008, 16(7): 1189-1199.
[6]
ROBERT M A, CHAHAL P S, AUDY A, et al.Manufacturing of recombinant adeno-associated viruses using mammalian expression platforms [J].Biotechnol J, 2017, 12(3): 1600193.
[7]
SAMULSKI R J, MUZYCZKA N.AAV-mediated gene therapy for research and therapeutic purposes [J].Annu Rev Virol, 2014, 1(1): 427-451.
[8]
GRIEGER J C, CHOI V W, SAMULSKI R J.Production and characterization of adeno-associated viral vectors [J].Nat Protoc, 2006, 1(3): 1412-1428.
[9]
ISSA S S, SHAIMARDANOVA A A, SOLOVYEVA V V, et al.Various AAV serotypes and their applications in gene therapy: an overview [J].Cells, 2023, 12(5): 785.
[10]
MEIER A F, FRAEFEL C, SEYFFERT M.The interplay between adeno-associated virus and its helper viruses [J].Viruses, 2020, 12(6): 662.
[11]
派真生物.国际罕见病日丨派真生物GMP质粒获DMF备案,助力药物申报,为罕见生命点亮色彩! [EB/OL].(2023-03-02)[2023-10-11].https://www.packgene.cn/news-cn/dmf/.
[12]
FDA.List of drug master files (DMFs)[EB/OL].(2023-10-10)[2023-10-11].https://www.fda.gov/drugs/drug-master-files-dmfs/list-drug-master-files-dmfs.
[13]
POWELL S K, RIVERA-SOTO R, GRAY S J.Viral expression cassette elements to enhance transgene target specificity and expression in gene therapy [J].Discov Med, 2015, 19(102): 49-57.
[14]
BELL P, MOSCIONI A D, MCCARTER R J, et al.Analysis of tumors arising in male B6C3F1 mice with and without AAV vector delivery to liver [J].Mol Ther, 2006, 14(1): 34-44.
[15]
DONSANTE A, VOGLER C, MUZYCZKA N, et al.Observed incidence of tumorigenesis in long-term rodent studies of rAAV vectors [J].Gene Ther, 2001, 8(17): 1343-1346.
[16]
ROSAS L E, GRIEVES J L, ZARASPE K, et al.Patterns of scAAV vector insertion associated with oncogenic events in a mouse model for genotoxicity [J].Mol Ther, 2012, 20(11): 2098-2110.
[17]
CHANDLER R J, LAFAVE M C, VARSHNEY G K, et al.Vector design influences hepatic genotoxicity after adeno-associated virus gene therapy [J].J Clin Invest, 2015, 125(2): 870-880.
[18]
GRAY S J, FOTI S B, SCHWARTZ J W, et al.Optimizing promoters for recombinant adeno-associated virus-mediated gene expression in the peripheral and central nervous system using self-complementary vectors [J].Hum Gene Ther, 2011, 22(9): 1143-1153.
[19]
TENENBAUM L, CHTARTO A, LEHTONEN E, et al.Recombinant AAV-mediated gene delivery to the central nervous system [J].J Gene Med, 2004, 6(Suppl 1): S212-S222.
[20]
GEISLER A, FECHNER H.MicroRNA-regulated viral vectors for gene therapy [J].World J Exp Med, 2016, 6(2): 37-54.
[21]
WANG J H, GESSLER D J, ZHAN W, et al.Adeno-associated virus as a delivery vector for gene therapy of human diseases[J].Signal Transduct Target Ther, 2024, 9(1): 78.
[22]
PAN X F, YUE Y P, BOFTSI M, et al.Rational engineering of a functional CpG-free ITR for AAV gene therapy [J].Gene Ther, 2022, 29(6): 333-345.
[23]
BALAKRISHNAN B, JAYANDHARAN G R.Basic biology of adeno-associated virus(AAV) vectors used in gene therapy[J].Curr Gene Ther, 2014, 14(2): 86-100.
[24]
GEORGE L A, RAGNI M V, RASKO J E J, et al.Long-term follow-up of the first in human intravascular delivery of AAV for gene transfer: AAV2-hFIX16 for severe hemophilia B [J].Mol Ther, 2020, 28(9): 2073-2082.
[25]
SRIVASTAVA A, CARTER B J.AAV infection: protection from cancer [J].Hum Gene Ther, 2017, 28(4): 323-327.
[26]
NATHWANI A C, REISS U, TUDDENHAM E, et al.Adeno-associated mediated gene transfer for hemophilia B: 8 year follow up and impact of removing “empty viral particles” on safety and efficacy of gene transfer [J].Blood, 2018, 132(S1): 491.
[27]
NGUYEN G N, EVERETT J K, KAFLE S, et al.A long-term study of AAV gene therapy in dogs with hemophilia A identifies clonal expansions of transduced liver cells [J].Nat Biotechnol, 2021, 39(1): 47-55.
[28]
NAKAI H, IWAKI Y, KAY M A, et al.Isolation of recombinant adeno-associated virus vector-cellular DNA junctions from mouse liver [J].J Virol, 1999, 73(7): 5438-5447.
[29]
RUTLEDGE E A, RUSSELL D W.Adeno-associated virus vector integration junctions [J].J Virol, 1997, 71(11): 8429-8436.
[30]
YANG C C, XIAO X, ZHU X, et al.Cellular recombination pathways and viral terminal repeat hairpin structures are sufficient for adeno-associated virus integration in vivo and in vitro [J].J Virol, 1997, 71(12): 9231-9247.
[31]
CHANDLER R J, SANDS M S, VENDITTI C P.Recombinant adeno-associated viral integration and genotoxicity: insights from animal models [J].Hum Gene Ther, 2017, 28(4): 314-322.
[32]
DALWADI D A, TORRENS L, ABRIL-FORNAGUERA J,et al.Liver injury increases the incidence of HCC following AAV gene therapy in mice [J].Mol Ther, 2021, 29(2): 680-690.
[33]
GIL-FARINA I, FRONZA R, KAEPPEL C, et al.Recombinant AAV integration is not associated with hepatic genotoxicity in nonhuman primates and patients [J].Mol Ther, 2016, 24(6): 1100-1105.
[34]
MILLER D G, TROBRIDGE G D, PETEK L M, et al.Large-scale analysis of adeno-associated virus vector integration sites in normal human cells [J].J Virol, 2005, 79(17): 11434-11442.
[35]
SULLIVAN L, ZAHN M, FARINA I G, et al.Rare genomic integrations of AAV5-hFⅧ-SQ occur without evidence of clonal activation or gene-specific targeting [J].Mol Ther, 2021, 29(4): 425.
[36]
WANG P R, XU M, TOFFANIN S, et al.Induction of hepatocellular carcinoma by in vivo gene targeting [J].Proc Natl Acad Sci U S A, 2012, 109(28): 11264-11269.
[37]
LOU J, YAN W, LI Q Y, et al.LncRNA MEG8 plays an oncogenic role in hepatocellular carcinoma progression through miR-367-3p/14-3-3ζ/TGFβR1 axis [J].Neoplasma, 2021, 68(2): 273-282.
[38]
国家药品监督管理局药品审评中心.重组腺相关病毒载体类体内基因治疗产品临床试验申请药学研究与评价技术指导原则[EB/OL].(2024-01-19)[2024-06-04].https://www.cde.org.cn/zdyz/domesticinfopage?zdyzId-CODE=50e5084c5744f082a85dd7e4eb068703.
[39]
SABATINO D E, BUSHMAN F D, CHANDLER R J, et al.Evaluating the state of the science for adeno-associated virus integration: an integrated perspective [J].Mol Ther, 2022, 30(8): 2646-2663.
[40]
MILLER D G, PETEK L M, RUSSELL D W.Adeno-associated virus vectors integrate at chromosome breakage sites [J].Nat Genet, 2004, 36(7): 767-773.
[41]
WEBER T.Anti-AAV antibodies in AAV gene therapy: current challenges and possible solutions [J].Front Immunol, 2021, 12: 658399.
[42]
WANG D, TAI P W L, GAO G P.Adeno-associated virus vector as a platform for gene therapy delivery [J].Nat Rev Drug Discov, 2019, 18(5): 358-378.
[43]
IKEDA T, YAMAGUCHI Y, OYAMA H, et al.Higher-order structure of adeno-associated virus serotype 8 by hydrogen/deuterium exchange mass spectrometry [J].Viruses, 2024, 16(4): 585.
[44]
MENDELL J R, AL-ZAIDY S, SHELL R, et al.Single-dose gene-replacement therapy for spinal muscular atrophy [J].N Engl J Med, 2017, 377(18): 1713-1722.
[45]
MENG J S, HE Y, YANG H B, et al.Melittin analog p5RHH enhances recombinant adeno-associated virus transduction efficiency [J].J Integr Med, 2024, 22(1): 72-82.
[46]
EL ANDARI J, GRIMM D.Production, processing, and characterization of synthetic AAV gene therapy vectors [J].Biotechnol J, 2021, 16(1): e2000025.
[47]
国家药品监督管理局药品审评中心.体内基因治疗产品药学研究与评价技术指导原则(试行)[EB/OL].(2022-05-31)[2023-10-02].https://www.cde.org.cn/zdyz/domes-ticinfopage?zdyzIdCODE=c78a179af7edac00e6d8893dcd-fef01f.
[48]
基因治疗制品质量控制概述[J].中国药事,2023,37(6):611-644.
[49]
FDA.Guidance for industry: considerations for plasmid DNA vaccines for infectious disease indications [EB/OL].[2023-10-12].https://www.fda.gov/media/73667/download.
2024年第55卷第8期
24
6
0
引用本文
BibTeX
文章信息
doi: 10.16522/j.cnki.cjph.2024.08.015
  • 接收时间:2024-05-07
  • 首发时间:2026-11-18
  • 出版时间:2024-08-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2024-05-07
基金
作者信息
    1.上海药品审评核查中心,上海 201203
    2.华南农业大学,广东 广州 510642

通讯作者:

刘芬(1986—),女,高级工程师,从事药品监管科学研究。E-mail:
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2024.08.015
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏